The parent company, Decima Health owns all intellectual property including a key patent family, and has a wholly owned subsidiary, Bionona Ltd which operates as a trading company. The company markets the products under the Atopis brand.


The Company plans to:

  1. Bolster existing data with further data to further demonstrate efficacy.
  2. Develop an enriched bioactive formulation for increased efficacy and the ability for incorporation into an even wider range of creams and product formats.
  3. Perform one additional clinical trial in addition to the two already completed in order to test efficacy in cases of rosacea.
  4. Manage its patent potfolio in multiple jurisdictions.
  5. Maintain its sales operation and continue to gather market and user intelligence.
  6. Compile a compelling data dossier.